Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Friday 11 June 2021 5:21 pm

Covid: UK vaccine rollout hits 70m doses amid reopening calls

By: James Warrington

Add as a preferred source on Google
British Military Aid Vaccination Bus In Attempt To Halt The Spread Of The Delta Coronavirus Variant
The latest figures mean more than 55 per cent of people in the UK have been vaccinated

More than 70m doses of Covid-19 vaccines have now been administered across the UK, as MPs and business leaders hit back at a potential delay to lockdown easing.

The latest figures mean more than three-quarters (78 per cent) of people have now been vaccinated with a first dose, while over 55 per cent have had both doses.

The UK remains on track to offer a first dose to all adults by the end of July. NHS England this week extended invitations to everyone aged 25 and older.

A recent study by Public Health England (PHE) shows that two doses of the Covid-19 vaccines are highly effective against the new, more infectious Delta variant.

However, it emerged today that the government is considering a delay to the next easing of lockdown restrictions to give people more time to get vaccinated against the virus.

The final lifting of measures, originally planned for 21 June, could reportedly be pushed back by up to four weeks.

The British Medical Association today called for the date of the so-called freedom day to be pushed back due to concerns about “rapidly rising” cases.

But politicians and business leaders have hit back at warnings of a delay to the reopening, with many citing the UK’s rapid vaccination rollout.

Read more

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

Former prime minister Theresa May slammed the government over its approach to international travel and called for ministers to tell the public “we will not eradicate” Covid from the UK completely.

Speaking in the Commons yesterday, May said it was “incomprehensible” that despite the high vaccination rates the UK was the “most reluctant to give its citizens the freedoms those vaccinations should support”. 

Pub bosses have warned that sector confidence will be sapped further if the government delays the current road map out of lockdown restrictions and there is “no reason” for such delays.

The government has already moved forward appointments for second doses from 12 weeks to eight weeks in a bid to offer greater protection.

The public is being urged to come forward for their first and second jabs when eligible.

“Our Covid-19 vaccination programme continues at an unparalleled pace and we are almost at the final lap of the race to offer a dose to all adults by the end of July,” said health secretary Matt Hancock.

“The number of appointments booked over the past few days just goes to show how enthusiastic we are as a nation towards getting the vaccine – I urge all who are eligible to get their jab at the earliest possible opportunity.”

Read more

Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus

Trending Articles

  • City sizes up mystery Mahmood

  • Oura Ring 5 vs Google Fitbit Air: The battle of the fitness trackers 

  • McMurtry Spéirling Pure: the £1m electric hypercar redefining what speed means

  • Tiktok ‘confident’ ahead of Ofcom child safety probe

  • World Cup demand pushes price of private jet charters up 30 per cent

More from City PM

  • Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

    Business Wire
  • Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

    Business Wire
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • Wimbledon: Majority of £350,000 debentures sold to overseas fans

    Sport Business
    Previews: The Championships - Wimbledon 2026
  • Are office workers lonelier than they were during Covid WFH?

    Business
    A third of Brits feel lonely at work, with almost a fifth regularly going a full day without speaking to anyone.
  • Regulator wins decade-long pricing tussle with Pfizer

    Legal
    Hikma reported a jump in profit for 2024
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook